Nuvalent
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Nuvalent and other ETFs, options, and stocks.About NUVL
Nuvalent, Inc. is a clinical stage biopharmaceutical company, which focuses on creating precisely targeted therapies for patients with cancer. Its pipeline includes ROS1 NSCLC, ALK NSCLC and HER2 NSCLC.
CEOJames R. Porter
CEOJames R. Porter
Employees142
Employees142
HeadquartersCambridge, Massachusetts
HeadquartersCambridge, Massachusetts
Founded2017
Founded2017
Employees142
Employees142
NUVL Key Statistics
Market cap7.54B
Market cap7.54B
Price-Earnings ratio-19.53
Price-Earnings ratio-19.53
Dividend yield—
Dividend yield—
Average volume608.48K
Average volume608.48K
High today$104.70
High today$104.70
Low today$102.01
Low today$102.01
Open price$102.01
Open price$102.01
Volume1.22M
Volume1.22M
52 Week high$112.88
52 Week high$112.88
52 Week low$55.54
52 Week low$55.54
Stock Snapshot
As of today, Nuvalent(NUVL) shares are valued at $103.80. The company's market cap stands at 7.54B, with a P/E ratio of -19.53.
During the trading session on 2025-12-22, Nuvalent(NUVL) shares reached a daily high of $104.70 and a low of $102.01. At a current price of $103.80, the stock is +1.8% higher than the low and still -0.9% under the high.
Trading activity shows a volume of 1.22M, compared to an average daily volume of 608.48K.
Over the past 52 weeks, Nuvalent(NUVL) stock has traded between a high of $112.88 and a low of $55.54.
Over the past 52 weeks, Nuvalent(NUVL) stock has traded between a high of $112.88 and a low of $55.54.
Analyst ratings
100%
of 18 ratingsBuy
100%
Hold
0%
Sell
0%
People also own
Based on the portfolios of people who own NUVL. This list is generated using Robinhood data, and it’s not a recommendation.